Home | 7th Obesity & NASH Drug Development Summit 2023
HEPQuant – Transforming Liver Health
Home - The Coalition for 21st Century Medicine
Description: We are a medical diagnostics firm with patented and patent-pending technology for assessing liver function of Chronic Liver Disease patients.
HepQuant is a privately-held, early-stage medical diagnostics company with unique, patented and patent-pending technology for assessing liver function of patients with chronic liver disease. HepQuant technologies, licensed from the University of Colorado Denver (UCD), have been advanced with the intent to profoundly impact the liver disease landscape – including the research, treatment and patient communities – with diagnostic products that are accurate and minimally invasive.
Through its Investigational Device Exemption (IDE), HepQuant provides liver testing support services to liver research centers and pharmaceutical companies. The HepQuant tests are designed to evaluate the liver — and levels of hepatic impairment — regardless of the etiology of the liver disease. Specifically, the tests establish a Disease Severity Index score by measuring hepatic blood flow, portal blood flow, and portal-systemic shunt in patients suffering from chronic liver disease (CLD).
♦ EASL 2023 | Vienna, Austria | June 21-23, 2023 | Abstracts submitted
Home | 7th Obesity & NASH Drug Development Summit 2023
HEPQuant – Transforming Liver Health
Home - The Coalition for 21st Century Medicine